, Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota, Gastroenterology, vol.112, issue.5, pp.1448-56, 1997.
DOI : 10.1016/S0016-5085(97)70025-8
, Gastro-oesophageal reflux disease in primary care in Europe: Clinical presentation and endoscopic findings, European Journal of General Practice, vol.41, issue.4, pp.149-55, 1995.
DOI : 10.1136/gut.31.4.401
, The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus, The American Journal of Gastroenterology, vol.2, issue.suppl 1, pp.1900-1920, 2006.
DOI : 10.1111/j.1572-0241.2006.00630.x
, Omeprazole 10 Milligrams Once Daily, Omeprazole 20 Milligrams Once Daily, or Ranitidine 150 Milligrams Twice Daily, Evaluated as Initial Therapy for the Relief of Symptoms of Gastro-oesophageal Reflux Disease in General Practice, Scandinavian Journal of Gastroenterology, vol.36, issue.5703, pp.965-73, 1997.
DOI : 10.1046/j.1365-2036.1996.44186000.x
, Non-erosive reflux disease (NERD) - acid reflux and symptom patterns, Alimentary Pharmacology and Therapeutics, vol.40, issue.7, pp.537-582, 2003.
DOI : 10.1136/gut.49.5.624
, Responsiveness of measures of heartburn improvement in non-erosive reflux disease, Health and Quality of Life Outcomes, vol.5, issue.1, pp.32-39, 2007.
DOI : 10.1186/1477-7525-5-32
, diagnosis and treatment of non-erosive refl ux disease (NERD), Minerva Gastroenterol Dietol, vol.50, pp.215-241, 2004.
, Erosive Esophagitis and Nonerosive Reflux Disease (NERD), Journal of Clinical Gastroenterology, vol.41, issue.2, pp.131-138, 2007.
DOI : 10.1097/01.mcg.0000225631.07039.6d
, Predictors of treatment response in patients with non-erosive reflux disease, Alimentary Pharmacology and Therapeutics, vol.140, issue.2, pp.371-377, 2006.
DOI : 10.1016/S1542-3565(05)00023-6
, Histological consequences of gastroesophageal refl ux in man, Gastroenterology, vol.58, pp.163-74, 1970.
, Dilated intercellular spaces: A morphological feature of acid reflux-- damaged human esophageal epithelium, Gastroenterology, vol.111, issue.5, pp.1200-1205, 1996.
DOI : 10.1053/gast.1996.v111.pm8898633
, Altered intercellular glycoconjugates and dilated intercellular spaces of esophageal epithelium in reflux disease, Virchows Archiv, vol.436, issue.3, pp.207-223, 2000.
DOI : 10.1007/s004280050032
, Radial Distribution of Dilated Intercellular Spaces of the Esophageal Squamous Epithelium in Patients with Reflux Disease Exhibiting Discrete Endoscopic Lesions, Digestive Diseases, vol.22, issue.2, pp.208-220, 2004.
DOI : 10.1159/000080321
, What Parameters Are Relevant for the Histological Diagnosis of Gastroesophageal Reflux Disease without Barrett???s Mucosa?, Digestive Diseases, vol.22, issue.2, pp.196-201, 2004.
DOI : 10.1159/000080319
, Microscopic Esophageal Mucosal Injury in Nonerosive Reflux Disease, Clinical Gastroenterology and Hepatology, vol.5, issue.1, pp.4-16, 2007.
DOI : 10.1016/j.cgh.2006.08.006
, Circumferential and axial distribution of esophageal mucosal damage in reflux disease, Diseases of the Esophagus, vol.20, issue.3, pp.232-240, 2007.
DOI : 10.1111/j.1442-2050.2007.00678.x
, Microscopic esophagitis: interobserver consistency using consensus-based criteria, Gut, vol.56, pp.75-81, 2007.
, Minimal Change Esophagitis: Prospective Comparison of Endoscopic and Histological Markers between Patients with Non-Erosive Reflux Disease and Normal Controls Using Magnifying Endoscopy, Digestive Diseases, vol.22, issue.2, pp.221-228, 2004.
DOI : 10.1159/000080323
, Acid Challenge to the Human Esophageal Mucosa: Effects on Epithelial Architecture in Health and Disease, Digestive Diseases and Sciences, vol.200, issue.Suppl 1, pp.1488-96, 2005.
DOI : 10.1007/s10620-005-2867-3
, Esomeprazole therapy and esophageal histology in endoscopy-negative refl ux disease (ENRD) ? the CHEER Study, Gastroenterology, vol.124, p.416, 2003.
, Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus, Alimentary Pharmacology and Therapeutics, vol.25, issue.2, pp.313-322, 2006.
DOI : 10.1111/j.1572-0241.2002.05532.x
, Reversibility of GERD Ultrastructural Alterations and Relief of Symptoms After Omeprazole Treatment, The American Journal of Gastroenterology, vol.111, issue.2, pp.537-579, 2005.
DOI : 10.1046/j.1365-2036.17.s1.6.x
, Eff ects of long-term treatment with proton pump inhibitors in gastro-oesophageal refl ux disease on the histological fi ndings in the lower oesophagus, Scand J Gastroenterol, vol.35, pp.1125-1155, 2000.
, Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial, Gut, vol.57, issue.9, pp.1207-1220, 2008.
DOI : 10.1136/gut.2008.148833
, Standardization of Surgical Technique in Antireflux Surgery: The LOTUS Trial Experience, World Journal of Surgery, vol.34, issue.6, pp.995-1003, 2008.
DOI : 10.1007/s00268-007-9409-4
, The symptom-association probability: An improved method for symptom analysis of 24-hour esophageal pH data, Gastroenterology, vol.107, issue.6, pp.1741-1746, 1994.
DOI : 10.1016/0016-5085(94)90815-X
, Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations, Virchows Archiv, vol.5, issue.1, pp.31-40, 2009.
DOI : 10.1007/s00428-008-0704-8
, Eosinophilic Esophagitis in Children and Adults: A Systematic Review and Consensus Recommendations for Diagnosis and Treatment, Gastroenterology, vol.133, issue.4, pp.1342-63, 2007.
DOI : 10.1053/j.gastro.2007.08.017
, Optimal Thresholds and Discriminatory Power of 48-h Wireless Esophageal pH Monitoring in the Diagnosisof GERD, The American Journal of Gastroenterology, vol.37, issue.2, pp.1862-1871, 2007.
DOI : 10.1016/j.gassur.2005.07.011
, Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and Nissen fundoplication, Journal of Gastrointestinal Surgery, vol.2, issue.4, pp.333-374, 1998.
DOI : 10.1016/S1091-255X(98)80072-3
, Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery, Gut, vol.57, issue.2, pp.161-167, 2008.
DOI : 10.1136/gut.2007.133298
URL : http://gut.bmj.com/cgi/content/short/57/2/161
, Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole, Gastroenterology, vol.120, issue.7, pp.1599-606, 2001.
DOI : 10.1053/gast.2001.24840
, Initial control of acid refl ux aft er laparoscopic antirefl ux surgery (LARS) compared to chronic use of esomeprazole (ESO) 20 ? 40 mg daily, DDW Abstract Gastroenterology, vol.134, issue.1, p.125, 2008.
, Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial, Alimentary Pharmacology and Therapeutics, vol.89, issue.186, pp.639-686, 2006.
DOI : 10.1080/00365520410003362
, Th e Nordic GERD Study Group Comparison of outcome twelve years aft er antirefl ux surgery or omeprazole maintenance therapy for refl ux esophagitis, Clin Gastroenterol Hepatol, p.31, 2009.
, Duodenogastroesophageal reflux: Relationship to pH and importance in Barrett's esophagus, Gastroenterology, vol.107, issue.3, pp.747-54, 1994.
DOI : 10.1016/0016-5085(94)90123-6
, Esophagitis after Esomeprazole or LARS List of principal investigators at each center and country coordinators (continued) Hiller ø d Hiller ø d Hospital Per
, Universit ä tsklinikum Martin Fein J ö rn Maroske Wiesbaden Dr-Horst ? Schmidt-Kliniken GmbH Christian Ell K ö ln Uniklinik und Poliklinik f ü r Visceral-und Gef ä ß chirurgie Arnulf H ö lscher Hamburg Israelitisches Krankenhaus Hamburg Carsten Zornig T ü bingen Klinikum der Eberhard-Karls
, Asbj ø rn Stallemo Oslo Ullev å l universitetssykehus HF Olav Sandstad Troms ø